Results 61 to 70 of about 114,322 (384)

Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department

European Geriatric Medicine, 2022
To investigate the association of polypharmacy with adverse health outcomes, in relation to comorbidity and frailty. Excessive polypharmacy (≥ 10 medications) is highly prevalent in older adults at the emergency department and associated with falls ...
C. V. van Dam, Helena A Labuschagne, K. van Keulen, C. Kramers, E. E. Kleipool, E. Hoogendijk, W. Knol, P. Nanayakkara, Majon Muller, M. Trappenburg, Mike J.L. Peters   +10 more
semanticscholar   +1 more source

Is shared decision-making a determinant of polypharmacy in older patients with chronic disease? A cross-sectional study in Hubei Province, China

BMC Geriatrics, 2023
Background Shared decision-making(SDM) is recognized as an important means of managing polypharmacy among older people with chronic diseases. However, no studies have quantitatively measured the effect of SDM on polypharmacy.
Qiao Zong, Zhanchun Feng, Jia Wang, Zehao Zheng, Chaoyi Chen, Da Feng   +5 more
doaj   +1 more source

Medication Risk and Polypharmacy in Minority Older Adults [PDF]

, 2020
Medication Risk and Polypharmacy in Minority Older Adults Rusha Patel, Depts. of Biology and Chemistry, with Dr. Youssef Roman, VCU School of Pharmacy, Dr. Elvin Price, VCU School of Pharmacy, and Dr.
Patel, Rusha
core   +1 more source

Polypharmacy in elderly cancer patients : challenges and the way clinical pharmacists can contribute in resource-limited settings [PDF]

, 2019
The aim of this study was to address the problems associated with polypharmacy in elderly cancer patients and to highlight the role of pharmacists in such cases in resource‐limited settings.
Khanal, Saval, Shrestha, Sudip, Shrestha, Sunil   +2 more
core   +2 more sources

Polypharmacy among community-dwelling elderly in Singapore: Prevalence, risk factors and association with medication non-adherence

Proceedings of Singapore Healthcare, 2019
Background: Polypharmacy, given its link with drug interactions, potentially inappropriate medications and medication non-adherence, may pose a significant health risk, especially among the elderly.
Yi Wen Tan, Sumithra Suppiah, Mary Ann C Bautista, Rahul Malhotra   +3 more
doaj   +1 more source

Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil [PDF]

Revista Brasileira de Epidemiologia, 2020
: Objective: To estimate the prevalence of polypharmacy, describe the pharmacotherapeutic classes used, and investigate whether polypharmacy is associated with demographic and socioeconomic indicators, regardless of the number of diseases, among ...
Isabella Ribeiro Silva, Luana Giatti, Dora Chor, Maria de Jesus Mendes da Fonseca, Sotero Serrate Mengue, Francisco de Assis Acurcio, Mariana Linhares Pereira, Sandhi Maria Barreto, Roberta Carvalho de Figueiredo   +8 more
doaj   +1 more source

Italian guidelines on management of persons with multimorbidity and polypharmacy

Aging Clinical and Experimental Research, 2022
Multimorbidity and polypharmacy are emerging health priorities and the care of persons with these conditions is complex and challenging. The aim of the present guidelines is to develop recommendations for the clinical management of persons with ...
G. Onder, D. Vetrano, K. Palmer, C. Trevisan, L. Amato, F. Berti, A. Campomori, L. Catalano, A. Corsonello, Paola Kruger, G. Medea, A. Nobili, G. Trifirò, Simona Vecchi, N. Veronese, A. Marengoni   +15 more
semanticscholar   +1 more source

Deprescribing Leads to Improved Energy Intake among Hospitalized Older Sarcopenic Adults with Polypharmacy after Stroke

Nutrients, 2022
Evidence is scarce regarding the polypharmacy in patients with sarcopenia. The aim of this study was to investigate the effect of deprescribing for polypharmacy on the improvement of nutritional intake and sarcopenia in older patients with sarcopenia.
A. Matsumoto, Y. Yoshimura, H. Wakabayashi, E. Kose, F. Nagano, T. Bise, Y. Kido, S. Shimazu, A. Shiraishi   +8 more
semanticscholar   +1 more source

Antipsychotic Polypharmacy

Focus, 2020
Physicians who treat patients with schizophrenia frequently encounter complex clinical situations not fully addressed by published treatment guidelines. Some of these situations lead to antipsychotic polypharmacy, often prescribed when clinical and social obstacles prevent access to clozapine and patients have had suboptimal responses to nonclozapine ...
Adriana, Foster, Jordanne, King
openaire   +3 more sources

Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study [PDF]

, 2013
Background Polypharmacy is increasing and managing large number of medicines may create a burden for patients. Many patients have negative views of medicines and their use can adversely affect quality of life.
A Alic, A Bowling, A Thompson, B Guthrie, BA Golomb, C Anderson, C Fox, C Salisbury, CA Anderson, CE Eades, DC Berry, DT Eton, DT Eton, F Stevenson, J Krska, J Krska, J Krska, J Krska, J Krska, JW Saultz, K Cox, L Ong, M May, MA Boustani, MA Hassali, MG Duerden, MJ Atkinson, N Britten, N Mead, P Pound, PA Rochon, R Adler, R Horne, RA Elliott, RA Elliott, S Kripalani, S Williams, SE Campbell, SN Weingart, T Kairuz, V Nunes   +40 more
core   +1 more source